Today: 7 February 2026
Subscribe

Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

New York, Jan 9, 2026, 20:08 EST — Market closed. Cisco Systems shares slipped slightly on Friday after the U.S. Supreme Court agreed to hear the company’s appeal in a lawsuit claiming it aided China in targeting Falun Gong practitioners. The stock closed down about 0.1% at $73.88. A Cisco spokesperson said the company welcomed the court’s decision and looked forward to oral arguments. (Reuters) The legal headline hits as U.S. stocks kick off 2026 on a strong note, valuations already running high with limited space for surprises. The S&P 500 closed at a record high on Friday, shrugging off
10 January 2026
····
Mastercard stock slips on ex-dividend day as Apple Card network win, CPI loom

Mastercard stock slips on ex-dividend day as Apple Card network win, CPI loom

NEW YORK, Jan 9, 2026, 20:10 EST — Market closed Mastercard (MA) shares fell 0.8% on Friday to $575.54, after trading between $575.00 and $581.26. The move came on a day Wall Street pushed higher, with the S&P 500 closing at a record after a softer December jobs report. The backdrop matters for payment networks because rate bets and growth fears can quickly spill into spending expectations. (Reuters) Away from the tape, Apple said JPMorgan Chase will become the new issuer of Apple Card, while Mastercard stays on as the payments network. “We’re thrilled to work with Apple and Chase
10 January 2026
····
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

New York, Jan 9, 2026, 20:01 (EST) — Market closed. Merck & Co (MRK.N) shares slipped on Friday following reports that the pharma giant is in talks to acquire cancer-focused biotech Revolution Medicines (RVMD.O) for as much as $32 billion. Merck ended the day down 0.4% at $110.53, after swinging between $110.26 and $112.46. (Reuters) The possible bid comes as Merck looks to bolster its oncology portfolio ahead of patent cliffs on its blockbuster Keytruda later this decade. Such a deal would arrive amid investor pressure on big pharma to weigh pipeline investments against buybacks and dividends, especially with interest
10 January 2026
·····
Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

NEW YORK, January 9, 2026, 20:00 EST — Market closed. Shares of The Goldman Sachs Group Inc (GS) closed Friday up roughly 0.4%, finishing at $938.98, gaining $4.15 from Thursday’s close. The stock fluctuated between $932.84 and $946.14 during the session, with around 1.1 million shares changing hands. Goldman now faces a hectic period as major U.S. banks prepare to kick off fourth-quarter earnings. Investors will be watching closely for early signals on the economy and deal activity. “The banks are going to be telling you something that is going to be pretty important because they’re on the front lines,”
10 January 2026
·····
Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape

Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape

New York, Jan 9, 2026, 20:26 EST — Market closed Shares of Credo Technology Group Holding Ltd (CRDO) climbed 6.2% to $150.42 on Friday. Needham stuck with a buy rating, set a $220 price target, and added the AI connectivity supplier to its conviction list. The stock fluctuated between $141.34 and $157.47, valuing the company at roughly $32.5 billion. (Investing.com) Money is pouring into the infrastructure supporting artificial-intelligence data centers, not just the big-name chipmakers. For smaller suppliers, one positive analyst call can spark a rapid influx of cash — and just as quickly, selling follows when the headlines shift.
10 January 2026
·····
BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

New York, January 9, 2026, 19:58 EST — After-hours BitMine Immersion Technologies, Inc. (BMNR) shares fell 3.9% to close at $30.06 on Friday following the appointment of Young Kim as CFO and COO. Trading volume hit around 37.6 million shares. The timing is crucial. BitMine’s annual shareholder meeting is just days away, and on the agenda is a proposal to raise its authorized share count — the limit in its charter on how many shares it can issue. The vote has kept the stock on edge, as investors debate how much leeway the company aims for in equity compensation and
10 January 2026
·····
NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

New York, Jan 9, 2026, 19:58 (ET) — After-hours NuScale Power Corp shares climbed late Friday following a Bank of America upgrade. The small modular reactor developer—known for its factory-built nuclear units—was raised to neutral with a $28 price target, MarketBeat said. The stock was last up 4.3% at $20.51, after reaching $22.49 earlier in the day, per market data. (MarketBeat) Timing is key. Wall Street has been factoring in a sharp rise in U.S. power demand driven by AI and data centers, bringing nuclear energy back into focus. On Friday, Meta Platforms inked 20-year deals to purchase power from
10 January 2026
·······
AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

New York, January 9, 2026, 20:18 (EST) — Market closed AbbVie Inc. shares dropped 1.8% on Friday, closing at $220.08. The decline followed the drugmaker’s decision to lower its 2025 earnings forecast and a denial of reports suggesting it was in talks to acquire cancer-drug developer Revolution Medicines. Since 2023, AbbVie has spent over $20 billion on acquisitions, aiming to offset the impact from Humira’s patent expiration. (Reuters) The updated forecast is crucial since AbbVie’s deals aim to replace lost growth, and this charge came late in the year when investors were already preparing for a rough transition from aging
10 January 2026
······
CrowdStrike stock bounces as $740 million SGNL deal and fresh upgrade shift focus to identity security

CrowdStrike stock bounces as $740 million SGNL deal and fresh upgrade shift focus to identity security

New York, Jan 9, 2026, 20:15 EST — Market closed CrowdStrike Holdings Inc shares gained 1.4%, closing at $470.61 on Friday, recovering some losses after the company announced a $740 million acquisition of identity security startup SGNL and received an analyst upgrade. The timing is crucial because “identity”—the log-ins and permissions controlling access to company data—has grown into a major vulnerability as firms link more cloud apps and test software “agents” operating with minimal human oversight. Security buyers are also looking to cut down on vendor numbers, a move that generally favors broad platforms over standalone products. (Nasdaq) CrowdStrike announced
10 January 2026
···
P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

NEW YORK, Jan 9, 2026, 20:06 EST — Market closed Procter & Gamble is changing the packaging and marketing for its Kid’s Crest toothpaste after Texas Attorney General Ken Paxton said label artwork encouraged unsafe fluoride use by children. Paxton said the rollout began on Jan. 1 and the company must keep the changes in place for five years. P&G said it was “fully committed to delivering safe, reliable products” and would ensure the artwork reflects recommended dosing levels for children, while Colgate-Palmolive reached a similar agreement in September. (Reuters) Why this matters now is less about one toothpaste box
10 January 2026
·····
Uber stock dips after CES robotaxi buzz meets fresh regulatory heat

Uber stock dips after CES robotaxi buzz meets fresh regulatory heat

NEW YORK, January 9, 2026, 20:06 EST — Market closed Uber Technologies (UBER) shares dropped 2.45%, closing at $85.44 on Friday and ending a three-day winning streak. The Nasdaq Composite climbed 0.81%, while DoorDash slid 3.81%, according to MarketWatch data. Uber’s volume came in at 15.4 million shares, below its 50-day average, with the stock finishing roughly 16% under its 52-week high. (MarketWatch) Talk of autonomous vehicles made a comeback at CES in Las Vegas. Nvidia unveiled a next-gen self-driving platform, set to power a robotaxi alliance involving Lucid, Nuro, and Uber, according to Reuters on Friday. Amazon Web Services
10 January 2026
····
Zillow stock stumbles after Mizuho downgrade flags listing-access fight and Flex legal risk

Zillow stock stumbles after Mizuho downgrade flags listing-access fight and Flex legal risk

NEW YORK, Jan 9, 2026, 19:26 EST Zillow Group shares fell on Friday after Mizuho downgraded the online real estate marketplace to Neutral from Outperform and cut its price target to $70 from $100, citing uncertainty over access to home listings and legal risks. Zillow’s class A shares (ZG) were down about 2% in late trade. (Investing.com Canada) The call lands at an awkward moment for Zillow. A court ruling tied to listings access is near, and brokers are pushing new “exclusive” or limited-release listings that could keep some homes off big portals, Mizuho warned. Mortgage rates have also jumped
10 January 2026
····
1 … 783 784 785 786 787 … 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop